CompletedNot Applicable

Feasibility and Acceptability of the Asynchronous eParenting CARE Program

Canada67 participantsStarted 2024-01-01

Plain-language summary

This study aims to evaluate the feasibility and acceptability of the eParenting CARE Program, an asynchronous, self-guided emotion-focused parenting intervention for parents of school-aged children (8-13 years). The eParenting CARE Program focuses on strengthening parent emotion regulation (ER) and supportive emotion socialization (ES) practices to promote children's ER and emotional well-being. Parent ER and ES are well-established predictors of children's emotional development, and difficulties in these domains are associated with increased risk for child emotional and behavioural problems. The long-term goal of this work is to improve family well-being and children's emotional functioning by developing an accessible and scalable online parenting intervention that can be delivered flexibly and with minimal barriers to participation. This pilot study will inform the refinement and future evaluation of the eParenting CARE Program through a feasibility-focused design. We will achieve this through the following key objectives: 1. Assess the feasibility and acceptability of the eParenting CARE Program for parents of school-aged children using indicators of recruitment, retention, program completion, and participant satisfaction. 2. Examine exploratory pre- to post-intervention changes in parent ER, parent ES behaviours, and parent-reported child ER to inform outcome selection and effect size estimation for future randomized controlled trials. 3. Identify implementation facilitators and barriers to participation in an asynchronous parenting program through qualitative feedback, including recommendations for improving engagement, accessibility, and program delivery. Findings from this pilot study will inform the development of future controlled trials and support the broader dissemination of accessible, emotion-focused parenting interventions aimed at promoting emotional well-being in parents and children.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Parent or legal guardian (e.g., custodial guardian) of a child aged 8 to 13 years at the time of enrollment
. Parent or guardian resides in Canada
. Ability to read, write, and understand English sufficiently to complete study materials and questionnaires
. Access to a reliable internet connection and a compatible digital device (e.g., computer, tablet, or smartphone)

Exclusion criteria

. Parent or guardian of a child outside the target age range (younger than 8 years or older than 13 years)
. Residence outside of Canada
. Insufficient proficiency in written or spoken English to complete intervention content or study assessments

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Program Feasibility (Recruitment, Retention, and Completion)

Timeframe: From enrollment through completion of the intervention (5 weeks)

Program Acceptability (Participant Satisfaction)

Timeframe: Post-Intervention (T2) - 5 weeks after program onset implementation

Participant Engagement with the Intervention

Timeframe: Throughout the intervention period (5 weeks)

Implementation Barriers and Facilitators (Qualitative Interviews)

Timeframe: Post-Intervention (within 2-4 weeks following program completion)

Trial details

NCT IDNCT07427771

SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-08-31

View on ClinicalTrials.gov More Emotion Regulation Abilities trials